BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32679275)

  • 1. The role of dupilumab in the management of idiopathic chronic eczematous eruption of aging.
    Shahriari N; Strober B; Shahriari M
    J Am Acad Dermatol; 2020 Nov; 83(5):1533-1535. PubMed ID: 32679275
    [No Abstract]   [Full Text] [Related]  

  • 2. A possible role for dupilumab (Dupixent) in the management of idiopathic chronic eczematous eruption of aging.
    Brummer GC; Wang LT; Sontheimer RD
    Dermatol Online J; 2018 Feb; 24(2):. PubMed ID: 29630150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dupilumab for severe generalized eczematous eruption complicating common variable immunodeficiency.
    Votquenne N; Dupire G; Michel O; Ben Said B
    Eur J Dermatol; 2021 Feb; 31(1):93-94. PubMed ID: 33586652
    [No Abstract]   [Full Text] [Related]  

  • 4. Dupilumab use in dermatologic conditions beyond atopic dermatitis - a systematic review.
    Hendricks AJ; Yosipovitch G; Shi VY
    J Dermatolog Treat; 2021 Feb; 32(1):19-28. PubMed ID: 31693426
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnostic testing of eczematous dermatitis with incomplete response to dupilumab.
    Bai H; Murase EM; Ashbaugh AG; Botto NB; Murase JE
    J Am Acad Dermatol; 2022 Sep; 87(3):692-695. PubMed ID: 35367296
    [No Abstract]   [Full Text] [Related]  

  • 6. Dupilumab to Treat Chronic Palmoplantar Eczema: A Retrospective Multicenter Cohort Study.
    Magdaleno-Tapial J; Torrijos Aguilar A; González-Delgado V; Hernández-Bel P
    Actas Dermosifiliogr; 2024 Jun; 115(6):628-631. PubMed ID: 38373606
    [No Abstract]   [Full Text] [Related]  

  • 7. Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab.
    Megna M; Genco L; Noto M; Patruno C; Fabbrocini G; Napolitano M
    Dermatol Ther; 2022 Nov; 35(11):e15839. PubMed ID: 36111349
    [No Abstract]   [Full Text] [Related]  

  • 8. Dupilumab treatment of nummular dermatitis: A retrospective cohort study.
    Choi S; Zhu GA; Lewis MA; Honari G; Chiou AS; Ko J; Chen JK
    J Am Acad Dermatol; 2020 May; 82(5):1252-1255. PubMed ID: 31923445
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunotherapy-induced eczema treated with dupilumab.
    D'Erme AM; Fidanzi C; Mori N; Musettini G; Cupini S; Barbara C; Allegrini G; Bagnoni G; Janowska A
    J Eur Acad Dermatol Venereol; 2024 May; 38(5):e447-e449. PubMed ID: 38084780
    [No Abstract]   [Full Text] [Related]  

  • 10. Machine learning analysis of pretreatment skin biopsies predicts nonresponse to dupilumab in patients with eczematous dermatitis.
    Murphy MJ; Hwang E; Singh K; Lee T; Cohen JM; Damsky W
    Br J Dermatol; 2023 Dec; 190(1):132-134. PubMed ID: 37818837
    [No Abstract]   [Full Text] [Related]  

  • 11. Eczematous reaction to ixekizumab successfully treated with dupilumab.
    Napolitano M; Gallo L; Patruno C; Fabbrocini G; Megna M
    Dermatol Ther; 2020 Mar; 33(2):e13218. PubMed ID: 31912951
    [No Abstract]   [Full Text] [Related]  

  • 12. Promising results for treatment of severe chronic hand eczema with dupilumab.
    Brans R
    Br J Dermatol; 2023 Sep; 189(4):360-361. PubMed ID: 37337439
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of chronic hand eczema with dupilumab-A retrospective follow-up study.
    Olesen CM; Yüksel YT; Zachariae C; Lund TT; Agner T; Petersen TS; Thyssen JP
    J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):e557-e559. PubMed ID: 36463422
    [No Abstract]   [Full Text] [Related]  

  • 14. A review of dupilumab in the treatment of atopic diseases.
    Thibodeaux Q; Smith MP; Ly K; Beck K; Liao W; Bhutani T
    Hum Vaccin Immunother; 2019; 15(9):2129-2139. PubMed ID: 30785362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for Successful Management of Severe Atopic Dermatitis.
    Brar KK; Nicol NH; Boguniewicz M
    J Allergy Clin Immunol Pract; 2019 Jan; 7(1):1-16. PubMed ID: 30598172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful use of dupilumab to treat eczema in a child with X-linked agammaglobulinemia.
    Atwal S; Ong PY
    Ann Allergy Asthma Immunol; 2022 Sep; 129(3):384-386. PubMed ID: 35772636
    [No Abstract]   [Full Text] [Related]  

  • 17. Dupilumab treatment of eczema in a child with STAT3 hyper-immunoglobulin E syndrome.
    Wang HJ; Yang TT; Lan CE
    J Eur Acad Dermatol Venereol; 2022 May; 36(5):e367-e369. PubMed ID: 34927771
    [No Abstract]   [Full Text] [Related]  

  • 18. Kimura Disease of the Thigh Treated With Surgical Excision and Dupilumab.
    Huang HY; Yang CY; Yao WT; Chen YF; Yu CM; Tung KY; Tsai MF
    Ann Plast Surg; 2022 Mar; 88(1s Suppl 1):S110-S113. PubMed ID: 35225857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study.
    Oosterhaven JAF; Voorberg AN; Romeijn GLE; de Bruin-Weller MS; Schuttelaar MLA
    J Dermatol; 2019 Aug; 46(8):680-685. PubMed ID: 31187925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dupilumab for Dyshidrotic Eczema With Secondary Improvement in Eosinophilic Interstitial Lung Disease.
    Levin NJ; Seger EW; Neill BC; Wang T
    Cutis; 2023 Nov; 112(5):E16-E17. PubMed ID: 38091430
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.